Clinical trial
A Prospective and Multicentric Investigation Evaluating the Clinical Safety of FASY F and FASY P Hyaluronic Acid Gel for the Treatment of Pathological Facial Lipoatrophy
NCT05776836 is registered in ClinicalTrials.gov with Symatese as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective and Multicentric Investigation Evaluating the Clinical Safety of FASY F and FASY P Hyaluronic Acid Gel for the Treatment of Pathological Facial Lipoatrophy
- Lead sponsor
- Symatese
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 28, 2023
- Completion date
- November 26, 2024
- Enrollment
- 30 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
facial lipoatrophy (fla)